Fed-Batch Cell Culture Methods Using Non-Animal-Based Hydrolysates
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 60/845,158, filed Sep 13, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,663,945 | Methods of Producing Anti-TNF-alpha Antibodies in Mammalian Cell Culture In force · High confidence | Abbott Laboratories | In force | High confidence | ||
| US 8,906,646 | Fed-Batch Method of Making Human Anti-TNF-Alpha Antibody In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 8,911,964 | Fed-Batch Method of Making Human Anti-TNF-Alpha Antibody In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,073,988 | Fed Batch Method of Making Anti-TNF-Alpha Antibodies In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,090,867 | Fed-Batch Method of Making Anti-TNF-alpha Antibody In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,234,032 | Fed-Batch Methods for Producing Adalimumab In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,284,371 | Methods of Producing Adalimumab In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 10,119,118 | A Modified Serum-Free Cell Culture Medium In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 8,093,045 | Fed-Batch Cell Culture Methods Using Non-Animal-Based Hydrolysates In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| Application 14/156,829 | Cell Culture Improvements Abandoned Abandoned Oct 3, 2015 | AbbVie Inc. | Abandoned | Abandoned Oct 3, 2015 | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 8 expiring within the 18 months from Nov 16, 2026.
8 of these are in force and held by AbbVie Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.